Format

Send to

Choose Destination
Cancer Res. 2010 Jan 1;70(1):192-201. doi: 10.1158/0008-5472.CAN-09-2641. Epub 2009 Dec 8.

ZBRK1 acts as a metastatic suppressor by directly regulating MMP9 in cervical cancer.

Author information

1
Institute of Basic Medical Sciences, National Cheng Kung University, Department of Pathology, Tainan, Taiwan.

Abstract

The BRCA1-interacted transcriptional repressor ZBRK1 has been associated with antiangiogenesis, but direct evidence of a tumor suppressor role has been lacking. In this study, we provide evidence of such a role in cervical carcinoma. ZBRK1 levels in cervical tumor cells were significantly lower than in normal cervical epithelial cells. In HeLa cervical cancer cells, enforced expression inhibited malignant growth, invasion, and metastasis in a variety of in vitro and in vivo assays. Expression of the metalloproteinase MMP9, which is known to be an important driver of invasion and metastasis, was found to be inversely correlated with ZBRK1 in tumor tissues and a target for repression in tumor cells. Our findings suggest that ZBRK1 acts to inhibit metastasis of cervical carcinoma, perhaps by modulating MMP9 expression.

PMID:
19996286
PMCID:
PMC3237114
DOI:
10.1158/0008-5472.CAN-09-2641
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center